1. Home
  2. CMTL vs GANX Comparison

CMTL vs GANX Comparison

Compare CMTL & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMTL
  • GANX
  • Stock Information
  • Founded
  • CMTL 1967
  • GANX 2017
  • Country
  • CMTL United States
  • GANX United States
  • Employees
  • CMTL N/A
  • GANX N/A
  • Industry
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMTL Technology
  • GANX Health Care
  • Exchange
  • CMTL Nasdaq
  • GANX Nasdaq
  • Market Cap
  • CMTL 51.3M
  • GANX 45.8M
  • IPO Year
  • CMTL N/A
  • GANX 2021
  • Fundamental
  • Price
  • CMTL $1.35
  • GANX $1.85
  • Analyst Decision
  • CMTL Strong Buy
  • GANX Strong Buy
  • Analyst Count
  • CMTL 1
  • GANX 6
  • Target Price
  • CMTL $9.25
  • GANX $8.33
  • AVG Volume (30 Days)
  • CMTL 200.9K
  • GANX 272.1K
  • Earning Date
  • CMTL 06-17-2025
  • GANX 05-13-2025
  • Dividend Yield
  • CMTL N/A
  • GANX N/A
  • EPS Growth
  • CMTL N/A
  • GANX N/A
  • EPS
  • CMTL N/A
  • GANX N/A
  • Revenue
  • CMTL $496,641,000.00
  • GANX N/A
  • Revenue This Year
  • CMTL N/A
  • GANX N/A
  • Revenue Next Year
  • CMTL $4.14
  • GANX N/A
  • P/E Ratio
  • CMTL N/A
  • GANX N/A
  • Revenue Growth
  • CMTL N/A
  • GANX N/A
  • 52 Week Low
  • CMTL $1.21
  • GANX $0.89
  • 52 Week High
  • CMTL $5.16
  • GANX $3.65
  • Technical
  • Relative Strength Index (RSI)
  • CMTL 41.05
  • GANX 48.82
  • Support Level
  • CMTL $1.19
  • GANX $1.67
  • Resistance Level
  • CMTL $1.43
  • GANX $1.82
  • Average True Range (ATR)
  • CMTL 0.13
  • GANX 0.18
  • MACD
  • CMTL 0.01
  • GANX 0.02
  • Stochastic Oscillator
  • CMTL 42.11
  • GANX 74.30

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: